These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 24844925)

  • 21. In vivo evaluation of guargum-based colon-targeted oral drug delivery systems of celecoxib in human volunteers.
    Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS; Bhaskar P
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):273-80. PubMed ID: 12587957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
    Asghar LF; Chandran S
    Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer.
    Sinha VR; Bhinge JR; Kumria R; Kumar M
    Drug Deliv; 2006; 13(3):221-5. PubMed ID: 16556575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical delivery of celecoxib using microemulsion.
    Subramanian N; Ghosal SK; Moulik SP
    Acta Pol Pharm; 2004; 61(5):335-41. PubMed ID: 15747689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
    Ha ES; Ok J; Noh J; Jeong HY; Choo GH; Jung YS; Baek IH; Kim JS; Cho W; Hwang SJ; Kim MS
    Int J Biol Macromol; 2015 Jan; 72():1473-8. PubMed ID: 25451745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis.
    Patel NV; Patel JK; Shah SH; Patel JN
    Pharmazie; 2011 Feb; 66(2):124-9. PubMed ID: 21434575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties.
    Gupta VR; Mutalik S; Patel MM; Jani GK
    Acta Pharm; 2007 Jun; 57(2):173-84. PubMed ID: 17507314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis.
    Ramasamy T; Ruttala HB; Shanmugam S; Umadevi SK
    Drug Deliv; 2013 Feb; 20(2):65-77. PubMed ID: 23537465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and in vitro/in vivo characterization of curcumin microspheres intended to treat colon cancer.
    Madhavi M; Madhavi K; Jithan AV
    J Pharm Bioallied Sci; 2012 Apr; 4(2):164-71. PubMed ID: 22557928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of microcrystal formulation on in vivo absorption of celecoxib in rats.
    Nasr M
    AAPS PharmSciTech; 2013 Jun; 14(2):719-26. PubMed ID: 23543607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albumin microspheres as carriers for the antiarthritic drug celecoxib.
    Thakkar H; Sharma RK; Mishra AK; Chuttani K; Murthy RR
    AAPS PharmSciTech; 2005 Sep; 6(1):E65-73. PubMed ID: 16353965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
    Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
    Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges.
    Orlu M; Cevher E; Araman A
    Int J Pharm; 2006 Aug; 318(1-2):103-17. PubMed ID: 16687222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
    He X; Barone MR; Marsac PJ; Sperry DC
    Int J Pharm; 2008 Apr; 353(1-2):176-86. PubMed ID: 18207339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
    Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
    Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery.
    Jain SK; Gupta Y; Jain A; Bhola M
    Drug Deliv; 2007 Aug; 14(6):327-35. PubMed ID: 17701522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model.
    Gugulothu D; Kulkarni A; Patravale V; Dandekar P
    J Pharm Sci; 2014 Feb; 103(2):687-96. PubMed ID: 24375287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
    Chawla A; Sharma P; Pawar P
    Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L100-55.
    Zaghloul AA; Vaithiyalingam SR; Faltinek J; Reddy IK; Khan MA
    J Microencapsul; 2001; 18(5):651-62. PubMed ID: 11508770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.